Verdence Capital Advisors LLC Rockwell Medical, Inc. Transaction History

Verdence Capital Advisors LLC

  • $1.23 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 24, 2023
SELL
$1.03 - $2.62 $51,491 - $130,979
-49,992 Reduced 78.49%
13,697 $24,000
Q3 2022

Nov 15, 2022
SELL
$1.2 - $2.11 $9,600 - $16,880
-8,000 Reduced 11.16%
63,689 $84,000
Q2 2022

Aug 08, 2022
BUY
$1.28 - $4.84 $91,761 - $346,974
71,689 New
71,689 $92,000

Others Institutions Holding RMTI

# of Institutions
63
Shares Held
9.46M
Call Options Held
339K
Put Options Held
43.3K
View Full List

About ROCKWELL MEDICAL, INC.

RMTI Quotes by TradingView
  • Ticker RMTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 10,675,200
  • Market Cap $24M
  • Description
  • Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iro...
More about RMTI
Track This Portfolio

Track Verdence Capital Advisors LLC Portfolio

Follow Verdence Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verdence Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verdence Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email